Paragraph IV Disputes Master Symposium

American Conference Institute

Event Info

  • Date:

    10.2.2017 - 10.3.2017

  • Time:

    9:00 am - 5:00 pm CDT

  • Location:

    Chicago, Illinois


  • Ethics Lab for Paragraph IV Practice: Identifying and Avoiding Ethics Pitfalls in Hatch-Waxman Litigation
    (David G. Conlin, Speaker )
  • Novartis v. Noven – A Study in Obvious Contrasts: Dilemmas Associated with Different Standards of Review
    (Kathleen B. Carr, Speaker )

Event Details

ACI’s industry-leading Paragraph IV Disputes Master Symposium enters its fifth iteration this fall. This event will pick up where ACI Paragraph IV conference left off to bring you up-to-the minute information on the latest developments affecting ANDA litigation.

Preeminent patent litigators representing brand name and generic drug makers, leading in-house counsel, and esteemed jurists will provide insights on such matters as:

  • The impact of TC Heartland on jurisdiction and venue
  • The legal and business repercussions of Helsinn
  • Amgen v. Sandoz from an ANDA litigator’s point of view
  • The FDA Final MMA Rule
  • Novartis v. Noven and differing standards of review
  • Secondary considerations in obviousness reviews
  • Alternative forums: PTAB and ITC
  • Oil States vs. Greene’s Energy Group and the constitutionality of IPR proceedings
  • Exceptional case findings
  • Reverse payment settlements
  • Patent lawsuit risk assessment and other IP due diligence essentials